<DOC>
	<DOCNO>NCT02966626</DOCNO>
	<brief_summary>Type 2 diabetes create health pandemic globally . Management type 2 diabetes involves combination lifestyle intervention drug intervention , include sodium-glucose transporter 2 ( SGLT-2 ) inhibitor , dapagliflozin . Dapagliflozin ( ForxigaÂ® ) approve Malaysian Drug Authority treatment type 2 diabetes 2014 . This study describe characteristic patient prescribed dapagliflozin diabetologists/endocrinologists tertiary referral center describe glycaemic control , weight , renal function baseline use dapagliflozin .</brief_summary>
	<brief_title>Real World Experience Dapaglifozin Type 2 Diabetes</brief_title>
	<detailed_description>The prevalence type 2 diabetes among adult &gt; 18 year old 17.5 % Malaysia , half undiagnosed . Diabetes also account 14.5 % all-cause mortality worldwide , close half death subject &lt; 60 year old . These highlight importance early diagnosis disease , timely intervention appropriate therapy , treat type 2 diabetes patient goal prevent development complication . Asian type 2 diabetes phenotype different Caucasians , i.e . significant pancreatic beta-cell dysfunction , high visceral adiposity , vulnerable cardio-renal complication . Although clinical trial SGLT-2 inhibitor publish , real-world data use new class antidiabetic medication still lack , particularly among Asians .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Diagnosis type 2 diabetes prior first prescription dapaglifozin Patients type 2 diabetes initiate dapaglifozin March 2014 till December 2015 Patients need dapaglifozin therapy least six consecutive month index date Patients need diabetologists/endocrinologists ' follow least six month initiation dapaglifozin Patients type 2 diabetes initiate dapaglifozin December 2015 Patients incomplete electronic medical record Patients Type 1 diabetes Patients latent autoimmune diabetes adult ( LADA ) Female Patients T2DM find pregnant treatment period dapaglifozin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Pragmatic , Sodium-Glucose Transporter 2 inhibitor , Malaysia</keyword>
</DOC>